CHUKWUDI OKEKE: Open Payments
NPI 1518672096 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$715 in 40 payments from 9 companies in 2025. Trend: 2023 $980 · 2024 $858 · 2025 $715
Food & beverage: $715
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $195 |
| Vanda Pharmaceuticals Inc. | 5 | $168 |
| Corium, LLC | 5 | $146 |
| Janssen Pharmaceuticals, Inc | 3 | $68 |
| Alkermes, Inc. | 2 | $39 |
| Neurocrine BioSciences, Inc. | 1 | $37 |
| Tris Pharma Inc | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
Products named: VRAYLAR, Azstarys, HETLIOZ, SPRAVATO, INGREZZA, FANAPT, Dyanavel XR, ARISTADA.
Industry payments across TX — which companies pay providers there.
